Clinical Trial Detail

NCT ID NCT02003573
Title Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

acute myeloid leukemia

Therapies

Decitabine + Volasertib

Age Groups: senior

No variant requirements are available.